Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2001;9(1):9–15. doi: 10.1155/S1064744901000035

Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs. Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis

Jack Sobel 1,✉, Jeffrey F Peipert 2, James A McGregor 3, Charles Livengood 4, Maureen Martin 5, Jill Robbins 5, Charles P Wajszczuk 5
PMCID: PMC1784633  PMID: 11368263

Abstract

Objective: To compare the efficacy and safety of a 3-day regimen of clindamycin vaginal ovules with a 7-day regimen of clindamycin vaginal cream for the treatment of bacterial vaginosis (BV)

Methods: Women with a clinical diagnosis of BV were treated with a 3-day course of clindamycin ovules or a 7-day course of clindamycin cream administered intravaginally. Three hundred and eighty-four patients received study drug and were included in the evaluable patient population (ovule group, n = 204; cream group, n = 180). Assessments included pelvic examination and diagnostic testing. Primary efficacy endpoints were a resolution of two of three diagnostic criteria at the first follow-up visit and three of three diagnostic criteria at the second.

Results: Cure rates in the evaluable patient population were similar between treatment groups: 53.7% (109/204) for the ovule group and 47.8% (85/180) for the cream group (p = 0.2471, 95% CI– 4.1–16.0%). The most commonly reported medical event, vulvovaginal pruritus, had similar incidence in both treatment groups.

Conclusions: A 3-day course of clindamycin vaginal ovules is as effective and well-tolerated as a 7-day course of clindamycin vaginal cream in the treatment of BV.

Full Text

The Full Text of this article is available as a PDF (334.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed-Jushuf I. H., Shahmanesh M., Arya O. P. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group. Genitourin Med. 1995 Aug;71(4):254–256. doi: 10.1136/sti.71.4.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14–22. doi: 10.1016/0002-9343(83)91112-9. [DOI] [PubMed] [Google Scholar]
  3. Andres F. J., Parker R., Hosein I., Benrubi G. I. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J. 1992 Nov;85(11):1077–1080. doi: 10.1097/00007611-199211000-00006. [DOI] [PubMed] [Google Scholar]
  4. Dhar J., Arya O. P., Timmins D. J., Moss S., Mukembo S., Alawattegama A. B., Williams O. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study. Genitourin Med. 1994 Apr;70(2):121–123. doi: 10.1136/sti.70.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferris D. G., Litaker M. S., Woodward L., Mathis D., Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract. 1995 Nov;41(5):443–449. [PubMed] [Google Scholar]
  6. Fischbach F., Petersen E. E., Weissenbacher E. R., Martius J., Hosmann J., Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 1993 Sep;82(3):405–410. [PubMed] [Google Scholar]
  7. Gravett M. G., Hummel D., Eschenbach D. A., Holmes K. K. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol. 1986 Feb;67(2):229–237. doi: 10.1097/00006250-198602000-00013. [DOI] [PubMed] [Google Scholar]
  8. Hay P. E. Therapy of bacterial vaginosis. J Antimicrob Chemother. 1998 Jan;41(1):6–9. doi: 10.1093/jac/41.1.6. [DOI] [PubMed] [Google Scholar]
  9. Joesoef M. R., Schmid G. P., Hillier S. L. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis. 1999 Jan;28 (Suppl 1):S57–S65. doi: 10.1086/514725. [DOI] [PubMed] [Google Scholar]
  10. Lamont R. F., Taylor-Robinson D., Newman M., Wigglesworth J., Elder M. G. Spontaneous early preterm labour associated with abnormal genital bacterial colonization. Br J Obstet Gynaecol. 1986 Aug;93(8):804–810. doi: 10.1111/j.1471-0528.1986.tb07987.x. [DOI] [PubMed] [Google Scholar]
  11. Nugent R. P., Krohn M. A., Hillier S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991 Feb;29(2):297–301. doi: 10.1128/jcm.29.2.297-301.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peipert J. F., Montagno A. B., Cooper A. S., Sung C. J. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol. 1997 Nov;177(5):1184–1187. doi: 10.1016/s0002-9378(97)70038-3. [DOI] [PubMed] [Google Scholar]
  13. Schmitt C., Sobel J. D., Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol. 1992 Jun;79(6):1020–1023. [PubMed] [Google Scholar]
  14. Sobel J. D. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896–1903. doi: 10.1056/NEJM199712253372607. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES